SAB Biotherapeutics, Inc. (SABS) stock
SABSNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 4/30
$3.20+0.25 (+8.47%)
Close on Nov 18, 2026Market cap $291.16MP/E –Yield –
SAB Biotherapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
SAB Biotherapeutics's market cap was $259.66M on Nov 11, 2026, against $187.60M a year earlier. Over the last 5 years it ranged from $12.63M to $380.64M, with a median of $55.40M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $259.66M | +46.2% |
| 2025 | Dec 31, 2025 | $177.63M | +407.3% |
| 2024 | Dec 31, 2024 | $35.02M | -44.8% |
| 2023 | Dec 29, 2023 | $63.48M | +41.7% |
| 2022 | Dec 30, 2022 | $44.80M | -1.3% |
| 2021 | Dec 31, 2021 | $45.37M | – |
See a number that looks wrong?